Literature DB >> 23597193

miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.

Biyun Qian1, Subhasree A Nag, Yuliang Su, Sukesh Voruganti, Jiang-Jiang Qin, Ruiwen Zhang, William C S Cho.   

Abstract

MicroRNAs (miRNAs) are endogenous small non-coding RNAs that regulate gene expression by binding to the 3´untranslated region of target mRNA, resulting in posttranscriptional gene silencing via mRNA degradation or translation inhibition. miRNAs are involved in many biological processes including carcinogenesis. They can act as oncogenes or tumor suppressors and their aberrant expressions are intimately linked with cancer development and progression. Therefore, miRNAs have been utilized as potential biomarkers for cancer diagnosis, prognosis, as well as cancer therapeutic targets. Recently, it has been demonstrated that dietary and natural chemopreventive agents exert their anticancer activities through the regulation of one or more miRNAs. In addition to expounding the latest findings of miRNAs in cancer, this review also discusses the recent efforts on the translational research of miRNAs, with an emphasis on natural products in the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597193     DOI: 10.2174/15680096113139990031

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  17 in total

1.  Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.

Authors:  Qiang Zhao; Jun Cao; Yi-Chen Wu; Xiang Liu; Jing Han; Xian-Cong Huang; Lie-Hao Jiang; Xiu-Xiu Hou; Wei-Min Mao; Zhi-Qiang Ling
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.

Authors:  Maoxiao Feng; Xiaochuang Luo; Chunming Gu; Yumin Li; Xuejiao Zhu; Jia Fei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis.

Authors:  Yongsheng Zhang; Lu Han; Jian Pang; Yang Wang; Fan Feng; Qiyu Jiang
Journal:  Tumour Biol       Date:  2015-12-30

4.  Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.

Authors:  Feng Wang; Yanlei Ma; Huamin Wang; Huanlong Qin
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

5.  Bioinformatics Analysis of miRNAs and mRNAs Network-Xuefu Zhuyu Decoction Exerts Neuroprotection of Traumatic Brain Injury Mice in the Subacute Phase.

Authors:  Zhao-Yu Yang; Yao Wu; Xuexuan Li; Tao Tang; Yang Wang; Ze-Bing Huang; Rong Fan
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

Review 6.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

7.  MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.

Authors:  Keyan Zheng; Weicheng Liu; Ye Liu; Congqing Jiang; Qun Qian
Journal:  Oncol Lett       Date:  2014-12-01       Impact factor: 2.967

8.  MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.

Authors:  Ben Liu; Jinli Qu; Fangxiu Xu; Yan Guo; Yu Wang; Herbert Yu; Biyun Qian
Journal:  Oncotarget       Date:  2015-04-20

9.  Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.

Authors:  Ruixue Tang; Lu Liang; Dianzhong Luo; Zhenbo Feng; Qiuxia Huang; Rongquan He; Tingqing Gan; Lihua Yang; Gang Chen
Journal:  Med Sci Monit       Date:  2015-08-25

10.  miR-195 is a key regulator of Raf1 in thyroid cancer.

Authors:  Fangzheng Wang; Chuner Jiang; Quanquan Sun; Fenqin Yan; Lei Wang; Zhenfu Fu; Tongxin Liu; Fujun Hu
Journal:  Onco Targets Ther       Date:  2015-10-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.